Loading institutional data...
Loading institutional data...
Held by 727 of 5,944 reporting institutions (98th percentile) — extremely crowded.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Solve the discounted cash flow backwards, then stress-test the assumptions.
To be worth $40.67 today, the market must believe free cash flow compounds 8.2%/yr for a decade (off $1.9B normalized FCF).
The market's 8.2% is more optimistic than its 9-yr track record.
2-stage DCF · 0.68B shares · net debt $11.9B
mean -40.5% · volatility σ 96% · implied rate exceeded in 2/6 yrs
Central path = implied 8.2%/yr growth; shaded band = ±1σ (96%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
EOD close · as of 2026-09-17
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $13.02B 100.0% | $11.30B 100.0% | $10.37B 100.0% | $4.11B 100.0% | $4.23B 100.0% | $2.94B 100.0% | $12.13B 100.0% | $13.73B 100.0% | $12.73B 100.0% | $11.27B 100.0% |
| Research & Development | $269.0M 2.1% | $228.0M 2.0% | $205.0M 2.0% | $143.0M 3.5% | $109.0M 2.6% | — | — | — | — | — |
| Selling, General & Admin | $1.19B 9.1% | $1.15B 10.2% | $1.11B 10.7% | $936.0M 22.8% | $831.0M 19.6% | $798.0M 27.1% | $1.12B 9.2% | $1.48B 10.8% | $1.42B 11.1% | $1.29B 11.4% |
| Total Operating Expenses | $10.20B 78.4% | $8.90B 78.7% | $8.06B 77.7% | $4.90B 119.3% | $4.92B 116.3% | $4.33B 147.4% | $8.76B 72.3% | $9.98B 72.7% | $9.26B 72.8% | $8.77B 77.8% |
| Operating Income | $2.82B 21.6% | $2.40B 21.3% | $2.31B 22.3% | -$792.0M -19.3% | -$689.0M -16.3% | -$1.39B -47.4% | $3.37B 27.7% | $3.75B 27.3% | $3.46B 27.2% | $2.50B 22.2% |
| Interest Expense | $746.0M 5.7% | $727.0M 6.4% | $818.0M 7.9% | $702.0M 17.1% | $621.0M 14.7% | $523.0M 17.8% | $449.0M 3.7% | $446.0M 3.2% | $327.0M 2.6% | $274.0M 2.4% |
| Interest & Investment Income | — | — | — | $116.0M 2.8% | $4.0M 0.1% | $21.0M 0.7% | $74.0M 0.6% | $59.0M 0.4% | $16.0M 0.1% | $10.0M 0.1% |
| Other Income (Expense), net | -$15.0M -0.1% | $10.0M 0.1% | -$8.0M -0.1% | -$9.0M -0.2% | -$31.0M -0.7% | $19.0M 0.6% | $56.0M 0.5% | $26.0M 0.2% | -$94.0M -0.7% | $31.0M 0.3% |
| Pretax Income | $2.21B 17.0% | $1.96B 17.3% | $1.77B 17.1% | -$1.39B -33.7% | -$1.47B -34.8% | -$1.88B -63.8% | $3.60B 29.7% | $3.33B 24.2% | $3.05B 24.0% | $2.26B 20.1% |
| Income Tax Expense | $347.0M 2.7% | $208.0M 1.8% | $344.0M 3.3% | $154.0M 3.7% | -$5.0M -0.1% | $24.0M 0.8% | $432.0M 3.6% | $375.0M 2.7% | -$209.0M -1.6% | $239.0M 2.1% |
| Net Income | $1.63B 12.5% | $1.45B 12.8% | $1.22B 11.8% | $1.83B 44.6% | -$961.0M -22.7% | -$1.69B -57.3% | $2.70B 22.2% | $2.41B 17.6% | $2.81B 22.1% | $1.68B 14.9% |
| Per Share | ||||||||||
| EPS (Basic) | $2.35 | $1.97 | $1.60 | $2.40 | $-1.26 | $-2.21 | $3.50 | $3.07 | $3.55 | $2.11 |
| EPS (Diluted) | $2.35 | $1.96 | $1.60 | $2.40 | $-1.26 | $-2.21 | $3.50 | $3.07 | $3.55 | $2.11 |
| Weighted Avg Shares (Basic) | 691.0M | 735.0M | 763.0M | 764.0M | 764.0M | 764.0M | 771.0M | 786.0M | 792.0M | 795.0M |
| Weighted Avg Shares (Diluted) | 693.0M | 737.0M | 765.0M | 764.0M | 764.0M | 764.0M | 771.0M | 786.0M | 792.0M | 795.0M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
7/8 of the 9 checks — 1 couldn't be scored (see above), so the score is out of the 8 with data.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81
Needs granular two-year detail (receivables, PP&E, D&A, SG&A) — not fully reported.
Earnings are backed by cash (FCF ≥ net income) — high quality. Lower/negative accruals = higher quality (Sloan).
Interest coverage is thin — monitor.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
The dividend is comfortably covered — only 45% of free cash flow, leaving room to grow it and fund buybacks. Last year: $833M dividends + $2.2B buybacks = $3.0B returned on $1.9B FCF.
3 consecutive years of dividend increases · -11%/yr.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A cash-return story — far more went to shareholders than back into the business (mature, low-reinvestment).
Modest payoff on reinvested capital. Current ROIC on all capital: 9%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $3.8B covers the $1.9B due within a year 2.0× over. Scheduled principal only (excludes interest & revolver draws). As of 2025-12-31 (10-K).
Insufficient EBITDA/debt history.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Coverage is adequate but not comfortable. Effective rate ~4.7% on $15.8B of debt.
Cash vs short-term debt unavailable.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
EOD close · as of 2026-09-17
No material risks flagged.
Where each multiple sits in its own 14-yr range · 45th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 14-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
Low operating leverage — profit tracks sales closely (stable, less cyclical).
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| R&D | — | — | — | 2.6 | 3.5 | 2.0 | 2.0 | 2.1 |
| SG&A | 10.8 | 9.2 | 27.1 | 19.6 | 22.8 | 10.7 | 10.2 | 9.1 |
| Operating Income | 27.3 | 27.7 | -47.4 | -16.3 | -19.3 | 22.3 | 21.3 | 21.6 |
| Income Tax | 2.7 | 3.6 | 0.8 | -0.1 | 3.7 | 3.3 | 1.8 | 2.7 |
| Net Income | 17.6 | 22.2 | -57.3 | -22.7 | 44.6 | 11.8 | 12.8 | 12.5 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on LVS: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
Ranked against 490 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AMZN | $2.70T | — | — | — | — | — | — | 20.5% | 16.2% | — | 5,764 |
| TSLA | $1.37T | 339.1× | 145.5× | 14.5× | -2.9% | 18.0% | 4.0% | 4.6% | 4.2% | 0.9× | 4,029 |
| TM | $614.2B | 60.0× | 24.8× | 2.6× | 3.8% | 18.4% | 4.4% | 7.9% | 5.9% | 1.7× | 665 |
| PDD | $442.6B | 32.9× | 31.9× | 7.2× | 14.5% | 56.3% | 22.7% | 23.7% | 23.7% | — | 548 |
| HD | $301.3B | 21.3× | 14.3× | 1.8× | 3.2% | 33.3% | 8.6% | 110% | 22.8% | 2.0× | 3,970 |
| BABA | $201.7B | 135.7× | — | 1.4× | 8.1% | 39.8% | 10.1% | 9.8% | 9.8% | — | 1,298 |
| TJX | $140.1B | 26.0× | — | 2.3× | 7.1% | 31.0% | 9.1% | 53.9% | 42.1% | — | 2,608 |
| HTHT | $132.7B | 187.9× | 114.3× | — | — | — | — | 39.7% | 27.3% | 0.7× | 258 |
| SBUX | $109.9B | 59.3× | 26.8× | 3.0× | 2.8% | — | 5.0% | -22.9% | 23.3% | 3.4× | 2,252 |
| LOW | $108.9B | 16.4× | 12.0× | 1.3× | 3.1% | 33.5% | 7.7% | -67.1% | 22.3% | 3.2× | 2,591 |
| ABNB | $101.7B | — | 37.9× | 8.3× | 10.3% | 83.0% | 20.5% | 30.6% | 24.6% | 0.8× | 1,246 |
| MELI | $92.5B | 46.3× | — | 3.2× | 39.1% | 44.5% | 6.9% | 29.6% | 12.5% | — | 1,380 |
| MAR | $88.8B | 35.1× | 20.6× | 3.4× | 4.3% | — | 9.9% | -69.0% | -69.4% | 0.0× | 1,559 |
| LKNCY | $86.3B | 168.2× | 90.8× | 12.3× | 48.9% | — | 7.3% | 23.0% | 23.0% | — | 9 |
| GM | $78.3B | 26.5× | 3.9× | 0.4× | -1.3% | — | 1.5% | 4.4% | 4.4% | — | 1,447 |
| ROST | $74.0B | 34.7× | 22.0× | 3.3× | 7.7% | 27.7% | 9.4% | 34.7% | 27.8% | 0.5× | 1,276 |
| ORLY | $71.5B | 28.6× | 19.5× | 4.0× | 6.4% | 51.6% | 14.3% | -333% | 48.3% | 1.5× | 1,569 |
| HLT | $69.7B | 49.4× | 24.0× | 5.8× | 7.7% | — | 12.1% | -27.0% | -27.0% | — | 1,126 |
| RCL | $67.7B | 16.0× | — | 3.8× | 8.8% | 49.4% | 23.8% | 42.5% | 32.3% | — | 1,114 |
| SE | $62.0B | 40.2× | 24.6× | 2.7× | 36.4% | 44.7% | 6.9% | 12.6% | 12.6% | — | 718 |
| F | $54.2B | — | 4.5× | 0.3× | 1.2% | 6.8% | -4.4% | -22.7% | -22.7% | — | — |
| NKE | $53.9B | 17.3× | — | 1.2× | 0.2% | 42.9% | 6.7% | 20.9% | 13.6% | — | 1,848 |
| EBAY | $50.7B | 26.0× | 18.4× | 4.6× | 7.9% | 71.5% | 18.3% | 45.3% | 38.8% | 0.3× | 1,182 |
| AZO | $47.8B | 19.6× | 13.3× | 2.5× | 2.4% | 52.6% | 13.2% | -73.2% | 46.4% | 2.1× | 1,245 |
| CMG | $44.8B | 29.4× | 19.4× | 3.8× | 5.4% | — | 12.9% | 54.3% | 54.3% | 0.0× | 1,203 |
| LVS | $27.5B | 17.3× | — | 2.1× | 15.2% | — | 12.5% | 102% | 9.4% | — | 727 |
Peers = companies sharing LVS's sector (Consumer Cyclical) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.